[Experience with the use of pharmacopoeial reference material for the activity of measles vaccine]
A S Binyatova1, T N Yunasova1, R A Volkova1
1Scientific Centre for Expert Evaluation of Medicinal Products.
Introduction:
Due to the increased incidence of measles in Russia and in many other regions of the world, vaccines for the measles prevention are especially in demand. Ensuring the quality of the measles vaccine for effective disease prevention is within the scope of the tasks of the state policy of our country.
Objective:
Evaluation of the experience of using a pharmacopoeial standard material of measles vaccine activity for measurement of the specific activity of the measles virus in vaccines with a measles component that are used in the Russian Federation for measles prevention.
Materials And Methods:
The object of the study was the Pharmacopoeia reference material (PRM) of the activity of the live measles vaccine of series 10. The activity of PRM was analyzed when determining the specific activity of the measles, mumps-measles and combined vaccines for the prevention of measles, rubella and mumps, as well as based on the materials of the summary protocols for the production of these vaccines.
Results:
The titer of the measles virus in the PRM for each determination of the specific activity of the measles virus in vaccines in the Scientific Centre for Expert Evaluation of Medicinal Products in 2021-2022, as well as according to the summary production protocols, was within the boundaries of the certified value (4.63 ± 0.5) lgTCD50/0.5 ml, and the test results met the acceptance criteria in accordance with the requirements of regulatory documentation. During the observation period, the average value of the PRM titer (4.61 lgTCD50/0.5 ml) practically did not differ compared to the average value of the certified characteristics of the PRM, the standard deviation of the mean value of the measles virus titer in the PRM did not exceed 0.15 lgTCD50, which indicated the stability of the analytical work at the enterprise and in IC.
Conclusion:
The data obtained indicate the stable activity of PRM, the correctness of the determination of the measles virus titer in the vaccination dose of the vaccine, and the validity of the method for monitoring the specific activity of the measles virus in vaccines.
Insights
This study confirms the stable activity of the measles vaccine pharmacopoeial reference material (PRM). This ensures accurate measurement of measles virus in vaccines, supporting effective disease prevention efforts.
Area of Science:
- Immunology
- Virology
- Pharmacology
Context:
- Rising global measles incidence necessitates robust vaccine quality control.
- Ensuring measles vaccine efficacy is a key public health policy objective.
Purpose:
- To evaluate the utility of a pharmacopoeial reference material (PRM) for quantifying measles vaccine activity.
- To assess the specific activity of measles virus in vaccines used for measles prevention in the Russian Federation.
Summary:
- The study analyzed a measles vaccine PRM (series 10) to determine measles virus specific activity in various vaccines.
- Results from 2021-2022 showed measles virus titers in the PRM consistently met certified values and acceptance criteria.
- The PRM demonstrated stable activity, supporting the accuracy of measles virus titer determination and vaccine monitoring.
Impact:
- Confirms the reliability of the PRM for measles vaccine quality assessment.
- Validates the methodology for monitoring measles virus specific activity in vaccine production.
- Contributes to ensuring the availability of high-quality measles vaccines for public health protection.
Related Concept Videos
Vaccinations
Allergic Drug Reactions
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Microorganisms in Medicine and Therapeutics


